The distribution of lesions in DNA caused by 8, 9, was studied in synchronized C3H/10T½ cells treated in S phase. Sites of carcinogen modification of DNA were identified by polyclonal rabbit antibodies elicited against DNA modified with B[aJP diol epoxide-I in vitro. This antigenic DNA contained trans-(7R)-N2- [10-(713,8a,9a-trihydroxy-7,8,9,10-tetrahydrobenzo[a] In the past, information concerning the effects of B[a]P diol epoxide-I exposure on DNA replication was obtained primarily from studies of the size distribution of nascent DNA molecules by using alkaline sucrose gradient sedimentation or alkaline elution (13, (18) (19) (20) (21) Eagle containing 10% (vol/vol) heat-inactivated fetal bovine serum, NaHCO3 at 2.2 g/liter, and Hepes at 6 g/liter (pH 7.2). Cells were incubated in a humidified atmosphere of 5% C02/95% air at 37°C. Stock cultures were maintained without the use of antibiotics and were routinely shown to be free of mycoplasma contamination (24) .
N2-[10-(713,8a,9a-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene)-yl]-deoxyguanosine; other adducts were not detected by liquid chromatography. In this study, DNA replication forks with antibodies bound to B[a]P diol epoxide-I adducts were detected by electron microscopy. The frequency of replication forks containing carcinogen adducts associated with the fork junction was found to be 8-fold higher than expected for an average distribution. The proportion of replication forks that were apparently blocked at the site of the DNA damage increased when replication was allowed to occur after carcinogen exposure. These results support the conclusions that the fork junction is particularly vulnerable to adduction by B[a]P diol epoxide-I and that B[a]P diol epoxide-I adducts block the displacement of replication forks during DNA synthesis in intact cells.
Proliferation of cells after exposure to chemical carcinogens is important to the initiation of malignant transformation. In studies of carcinogenesis in mouse skin, increased susceptibility to tumor formation correlated with increased DNA synthesis after carcinogen treatment (1, 2) . In partially hepatectomized rats, the maximal sensitivity to tumor formation in the liver was observed when carcinogen treatments occurred during the S phase of proliferating hepatocytes (3, 4) . Transformation of cells in culture is also dependent on cell proliferation and DNA replication immediately following the carcinogen treatment (5) . The maximal sensitivity to transformation of mouse fibroblasts was observed when cells were exposed to the carcinogenic agent during the early portion of the S phase (6, 7) . To investigate this sensitivity, we studied the effect of exposure to (±)-7,8,8a-dihydroxy-9a,lOa-epoxy-7,8,9,10-tetrahydrobenzo- [a] pyrene (B[a]P diol epoxide-I) on C3H/10T½ cells actively synthesizing DNA.
B[a]P diol epoxide-I, the ultimate carcinogenic metabolite of benzo [a] pyrene (8) , modifies nucleic acids by linkage of the exocyclic 2-amino group of guanine and the C-10 position of the B[a]P diol epoxide-I moiety (9) . The mechanisms by which B[a]P diol epoxide-I acts to induce malignant transformation are unclear. Evidence has been reported for the occurrence of specific mutations (10, 11) and cytogenetic changes, such as sister chromatid exchange (12) (13) (14) , in the DNA of cells exposed to B[a]P diol epoxide-I. In subcellular systems in vitro DNA synthesis is blocked at each DNA adduct encountered by the polymerase (15) (16) (17) . In eukaryotic systems DNA adducts block DNA chain elongation and cause gaps to be formed in nascent DNA (13, (18) (19) (20) (21) . However, in most nonlethal cases, DNA synthesis resumes with time, and gaps, as well as B[a]P diol epoxide-I-DNA adducts, decrease or disappear.
In the past, information concerning the effects of B[a]P diol epoxide-I exposure on DNA replication was obtained primarily from studies of the size distribution of nascent DNA molecules by using alkaline sucrose gradient sedimentation or alkaline elution (13, (18) (19) (20) (21) . Such studies depended on detection of changes in large populations of DNA molecules, and some correlated the number of B[a]P diol epoxide-I adducts present in DNA with the reduction in either the size of nascent DNA fragments (18) or the rate of DNA synthesis (21) . Correlations of this type permit only indirect inferences to be drawn concerning the effects of B[a]P diol epoxide-I adducts on DNA synthesis. In the present study a different approach was used that allows a direct analysis of the effect of B[a]P diol epoxide-I adducts on DNA replication. The basic methodology uses antibodies with high affinity for B[a]P diol epoxide-I adducts attached to the exocyclic nitrogen of deoxyguanosine in DNA and uses electron microscopy to visualize and quantitate antibodies bound to B[a]P diol epoxide-I DNA adducts (22 (24) .
Synchronization of Cell Populations. Cells were synchronized by growth arrest at confluence followed by replating at low density (6 . After 30 min, the medium was removed, cell cultures were rinsed twice with 5 ml of saline that contained aphidicolin at 2.0 ,ug/ml, and 20-,l aliquots of tetrahydrofuran-containing B[a]P diol epoxide-I were added to an additional 5 ml of saline with aphidicolin. Cultures were exposed to B[a]P diol epoxide-I for 10 min at room temperature, saline containing B[a]P diol epoxide-I was removed, and complete medium with aphidicolin was added to each dish. Cultures were incubated for 60 min at 37°C. In group II cells were rinsed twice with saline, and treated with B[a]P diol epoxide-I as described above, but in the absence of aphidicolin. Once B[a]P diol epoxide-I was removed, 5 ml of complete medium was added to each dish, and the cultures were incubated for 70 min at 37°C. At the end of the incubations at 37°C, DNA was purified from cell cultures from both group I and group II and later digested with the restriction endonuclease Pvu II (Bethesda Research Laboratories), as described (22) . DNA solutions in 10 mM Tris-HCI/100 mM NaCl/1 mM EDTA, pH 7.5, were divided into aliquots, and those that were not used immediately were stored at -20°C. Analysis by Electron Microscopy of Antibodies Bound to B[a]P Diol Epoxide-I Adducts. DNA samples from group I and group II were prepared for visualization of antibodies as described (22) . By using levels of modification as determined by ELISA, duplicate 20-,ug samples of DNA were incubated with -25 times the estimated minimal amount of B[a]P diol epoxide-I-DNA antiserum necessary to react fully with those adducts present. After 9 hr at 37°C, an equal volume of papain in 0.20 M potassium phosphate, pH 7.0/0.02 M L-cystine hydrochloride/0.004 M EDTA was added to the DNA-antibody reaction mixture. The papain solution was prepared such that 1 mg of papain would be added to the final solution for each 100 mg of protein already present in the DNA-antibody reaction mixture. After 15 hr at 37°C, the volume of the samples was reduced, and B[a]P diol epoxide-I-DNA-Fab complexes were separated from the digestion mixture by column exclusion chromatography. The complexes then were incubated with amounts of ferritin-conjugated univalent goat anti-rabbit F(ab')2 fragments that were =10 times the amount necessary to react with all of the rabbit B[a]P diol epoxide-I-DNA-Fab complexes present.
After incubation for 15 hr at 370C, sample volumes were again reduced, and DNA-antibody complexes were purified and prepared for analysis with the electron microscope. For analysis of the proximity of sites of carcinogen modification to the junction of DNA replication forks, DNA molecules were examined with the electron microscope in a systematic manner, so that each field was analyzed only once. When DNA molecules that resembled the "Y" conformation of DNA replication fork structures were visualized, they were examined at various magnifications. If these DNA molecules resembled replication fork structures, they were recorded as such. If a replication fork structure had an electron-dense ferritin molecule associated with it, a photograph was made of the DNA molecule at a magnification of x 50,000. In addition, after photographing a DNA molecule recorded as a replication fork with antibody, the next apparent DNA replication fork structure without antibody was photographed at the same magnification to create a parallel population of fork structures without antibodies. Subsequently, electron micrographs were closely inspected to confirm that the photographed DNA molecules resembled acceptable DNA replication fork structures. To be acceptable as an apparent fork structure, DNA molecules had to have three clearly discernable branches originating from one apparent junction. In addition, two of the three branches had to be of approximately the same length because the restriction endonuclease should cleave the two newly replicated daughter molecules at identical recognition sites. The fact that methylation at the internal cytosine of the Pvu II recognition sequence could prevent cutting at the methylated site should have no effect on our analyses. The frequency of methylated cytosines is small and both daughter DNA molecules should have the same methylation pattern (fully methylated, hemimethylated, or nonmethylated) at each individual site. Lengths of the strands of DNA fork structures were determined by tracing, as described (22) . Visualization of Antibodies Bound to Sites of Carcinogen Modification of DNA. Synchronized cell cultures were exposed for 10 min to 3.3 ,M B[a]P diol epoxide-I in mid-S phase and incubated for 60-70 min in medium free of carcinogen. Cell cultures in group I were maintained all the time in the presence of aphidicolin at 2.0 ,ug/ml, a potent inhibitor of DNA polymerase a (25) . Cell cultures of group II were exposed to carcinogen and incubated in the absence of aphidicolin. DNA was isolated and was prepared for visualization of antibody-bound sites of carcinogen modification. DNA replication forks were scored for the presence and the position of ferritin-labeled antibodies (Fig. 2) . In Table 1 we listed both the number of total fork structures tagged with a ferritin-labeled antibody anywhere in the DNA molecule and a subgroup of these fork structures in which the ferritinlabeled antibody was localized to the junction region of the replication forks [i.e., within 80 base pairs (bp) of the tranCell Biology: Paules et sition point between nonreplicated and daughter branches of the fork structures]. We observed that when replication was allowed to proceed after the exposure to B[a]P diol epoxide-I (group II), 27% of the observed fork structures had antibodies associated with them, as compared to 20% in group I (replication inhibited by aphidicolin). More specifically, DNA replication forks that had ferritin-labeled antibodies located at the junction region of the Y structures (Fig. 2) represented 8% of the total number of forks in group I and 13% in group II. The statistical significance of the difference between group I and group II in the number of DNA replication forks with ferritin-antibodies at the junction region was evaluated by a x2 test. The result was an 80%
RESULTS
probability of accepting as correct the conclusion that group II had more DNA replication forks containing ferritinlabeled antibodies at the junction region than group I. The distribution of ferritin-labeled antibodies bound to carcinogen-DNA adducts on DNA replication forks was analyzed for group I and group II. First, the replicated branches of the DNA replication forks were identified by their near-equal length from measurements of electron micrographs. Second, a junction region was designated as composed of three joint segments of 80 bp each that delimited an area of 160 bp in diameter, roughly corresponding to the diameter of the ferritin molecule. Third, we elected to divide the length of each branch, away from the junction region, into 230-bp segments. This distance corresponds approximately to the expected internucleosomal spacing (26) . Table 2 lists the DNA segments (distances from the fork junction region in base pairs) analyzed for group I and group II fork structures, the number of DNA molecules analyzed that contained each of these segments, and the total number Table 2 . This procedure is little affected by the small number of counts in the frequency distribution. The model assumed that the ferritin-labeled antibodies were distributed binomially along the length of the DNA. In concordance with the V2 test, the results of the logistic regression confirmed that a higher proportion of ferritinlabeled antibodies were found at the junction region of the fork at a highly significant level of P < 0.0001. As shown in The two experimental groups reported here differ based upon the extent of progression of DNA replication following carcinogen treatment. Cell cultures were allowed to replicate DNA for 70 min after carcinogen treatment (group II). As a control for the effect of DNA replication, parallel cultures were incubated with aphidicolin before, during, and after exposure to B[a]P diol epoxide-I to slow the displacement of DNA replication forks (group I).
We have estimated the probability of an active replication fork encountering a B[a]P diol epoxide-I-DNA adduct for each treatment group based on rates of DNA synthesis and levels of B[a]P diol epoxide-I modification of DNA. The level of modification for DNA from group II was 40.4 fmol of B[a]P diol epoxide-I-DNA adduct per Ag of DNA (26.9 adducts in 106 bp). Therefore, the average interadduct distance, assuming a random distribution of adducts, would be 37 kilobases (kb) of DNA. Thus, the average distance traversed by an initiated fork, from the time of treatment until it encounters an adduct, would be between 18 kb and 56 kb (0.5-1.5 times the interadduct distance). Cordeiro-Stone and Kaufman (27) (28, 29) . The smaller nascent DNA synthesized in cells treated with ultraviolet light or B[a]P diol epoxide-I are thought to be the consequence of the blockage of replication forks at lesions present in the template to the leading strand, and the formation of daughter-strand gaps opposite lesions in the template for the lagging strand (29) . In the present study we observed a statistically significant number of replication forks containing ferritin-labeled antibody complexes associated with the junction region. This localization is consistent with the blockage of replication forks by B[a]P diol epoxide-I adducts present in the template to the leading strand. Furthermore, we observed four to six times more adducts in the two daughter branches than in the parental branch (excluding those in the fork junction). These adducts found in replicated DNA were probably located in DNA strands that serve as template for the synthesis of the lagging strand. They would be expected to block the elongation of Okazaki fragments but not to interrupt the displacement of the replication fork (29) .
The results of electron microscopic visualization of antibodies bound to B[aJP diol epoxide-I-DNA adducts (Table 1) revealed that 27% of the observed DNA replication forks had antibodies attached to them in group II, as compared to the 20%o observed when aphidicolin was present (group I). Within this population of DNA replication forks labeled with antibodies, a statistically significant portion of the antibodies were found at thejunction region (Table 2) . From the total number of DNA replication forks with ferritin-labeled antibodies associated with them, 40%o in group I (12/30) and 49% in group II (21/43) had antibodies visualized at the fork junction region.
These results indicate that the increased localization of adducts at the fork junction cannot be explained only by the accumulation of forks arrested at an adduct when replication has reached this location. Whether replication progressed fast or slowly, most adducts were found in the junctional region of the fork. This suggests that a large fraction of the carcinogen binding occurred directly to DNA at the fork junction, presumably because of the structure of the fork and the specific vulnerability of replicating DNA (30, 31) . The persistence of this fraction of binding independent of the extent of replication suggests that many of these sites of adduction blocked further replication. The fact that less than a majority of forks have a demonstrable adduct may relate to (i) less than complete identification of adducts by antibody, (ii) adduction at the fork junction may increase the probability of fork breakage, (iii) repair processes may remove adducts ahead of replication forks, (iv) the replicon size in C3H/10T½ cells may be smaller than 60-135 kb, the range of replicon sizes reported for rodent cells (32) . Despite these possible confounding factors, our results indicate that the junction region of replication forks is particularly vulnerable to adduction by B[a]P diol epoxide-I and that DNA adducts block the displacement of replication forks. This may explain, in large measure, the vulnerability of proliferating cells to transformation.
